XOOMAR

Andreas Halvorsen portfolio, Viking Global Investors 13F holdings

Andreas Halvorsen. Quarterly 13F portfolio: every reported position with value, portfolio weight and the change in shares since the prior quarter.

Download CSV

2026-06-30

Quarter ended

$35.08B

Reported value

90

Positions

New positions
  • Ferrari
  • MSCI
  • Union Pacific
  • DLR
  • Carnival
Added to
  • Visa
  • Air Products & Chemicals
  • Sherwin-Williams
  • Meta Platforms
  • Thermo Fisher Scientific
Reduced
  • Taiwan Semiconductor Manufacturing
  • Fortive
  • Charles Schwab
  • McDonald's
  • BridgeBio Pharma

Holdings

#IssuerTickerValue% of PortfolioSharesQoQ Shares
1V$2.19B6.3%6.39M+65.4K
2TSM$1.51B4.3%3.17M-1.30M
3APD$1.39B4.0%4.74M+636.3K
4SHW$1.33B3.8%3.88M+763.1K
5FTV$1.22B3.5%19.93M-2.54M
6META$1.05B3.0%1.87M+805.0K
7SCHW$981.6M2.8%10.64M-4.03M
8TMO$971.3M2.8%1.94M+269.4K
9
JPMorgan Chase
JPM$949.1M2.7%2.90M+195.4K
10LII$911.5M2.6%1.59M+18.5K
11AMZN$882.1M2.5%3.70M+2.51M
12RACE$816.9M2.3%2.20M+2.20M
13
Carvana
CVNA$811.1M2.3%12.32M+9.54M
14MCD$764.7M2.2%2.83M-795.9K
15BBIO$741.0M2.1%9.95M-1.89M
16BA$708.9M2.0%3.27M+78.8K
17MAA$700.7M2.0%5.04M+244.9K
18DIS$689.0M2.0%7.16M-6.14M
19FDX$673.9M1.9%2.15M+219.8K
20MSCI$650.0M1.9%1.16M+1.16M
21
Adaptive Biotechnologies
ADPT$643.4M1.8%29.99M0
22WAT$623.4M1.8%1.66M+405.7K
23JCI$614.1M1.8%4.20M-217.2K
24UNP$556.9M1.6%2.05M+2.05M
25MSFT$544.1M1.6%1.46M-850.8K
26SE$543.3M1.5%5.67M+932.7K
27
CAMDEN PPTY TR
CPT$516.7M1.5%4.51M-202.1K
28RRX$500.6M1.4%2.10M-1.04M
29
Biomarin Pharmaceutical
BMRN$435.8M1.2%7.62M+554.5K
30IBKR$420.5M1.2%4.83M+3.44M
31
DIGITAL RLTY TR INC
DLR$414.9M1.2%2.31M+2.31M
32CCL$408.5M1.2%14.30M+14.30M
33
General Motors
GM$385.8M1.1%5.01M-4.17M
34AON$381.9M1.1%1.15M+64.2K
35
CVS Health
CVS$379.0M1.1%3.66M+3.66M
36FDXF$357.4M1.0%2.37M+2.37M
37ICE$341.9M1.0%2.78M-2.06M
38MS$339.2M1.0%1.62M+1.62M
39HD$324.7M0.9%920.6K+416.3K
40
TIC Solutions
TIC$289.8M0.8%35.82M0
41QCOM$279.8M0.8%1.51M+1.51M
42APTV$279.5M0.8%4.55M+4.55M
43RDDT$271.7M0.8%1.57M-986.1K
44HAS$256.6M0.7%3.11M-631.7K
45
AVALONBAY CMNTYS INC
AVB$252.8M0.7%1.34M+1.34M
46DKS$250.9M0.7%1.11M-158.0K
47
Snowflake
SNOW$244.4M0.7%960.1K+960.1K
48EQH$236.9M0.7%5.40M+5.40M
49TTWO$235.1M0.7%940.6K+940.6K
50TSLA$230.4M0.7%547.8K-1.95M
51
ATI
ATI$227.4M0.6%1.15M-2.18M
52ROIV$221.9M0.6%6.27M-381.0K
53SPCX$205.0M0.6%1.20M+1.20M
54
Amer Sports
AS$201.5M0.6%5.95M-1.32M
55
Veradermics
MANE$192.0M0.5%1.56M-129.1K
56MDLN$190.9M0.5%4.84M-6.59M
57
Bce
BCE$180.6M0.5%8.38M+8.38M
58USFD$177.3M0.5%1.73M+1.73M
59
Oruka Therapeutics
ORKA$143.1M0.4%1.50M-1.16M
60
NewAmsterdam Pharma
NAMS$142.5M0.4%4.20M0
61
Sionna Therapeutics
SION$140.6M0.4%3.20M0
62CB$128.6M0.4%377.3K-917.7K
63
Pharvaris
PHVS$126.3M0.4%3.65M0
64
UBS Group
UBS$120.8M0.3%2.44M+2.44M
65BTSG$112.9M0.3%1.62M+1.62M
66
Inhibrx Biosciences
INBX$106.5M0.3%1.12M-313.8K
67NTRA$106.1M0.3%390.7K+390.7K
68
Deutsche Bank Aktiengesellschaft
DB$85.0M0.2%2.51M+2.51M
69COF$77.8M0.2%387.8K-1.22M
70CRBG$76.7M0.2%2.68M+2.68M
71
Solaredge Technologies
SEDG$63.6M0.2%1.09M+1.09M
72
Damora Therapeutics
DMRA$60.1M0.2%2.31M0
73
Oric Pharmaceuticals
ORIC$55.5M0.2%5.13M-697.8K
74
Bruker
BRKR$53.8M0.2%893.5K+893.5K
75
Standard Biotools
LAB$48.3M0.1%58.65M0
76
Ginkgo Bioworks Holdings
DNA$35.4M0.1%3.58M0
77
CME Group
CME$33.8M0.1%153.0K+153.0K
78
Tradeweb Markets
TW$31.3M0.1%314.2K+314.2K
79
Trevi Therapeutics
TRVI$28.8M0.1%1.54M-1.65M
80
Infleqtion
INFQ$27.1M0.1%2.03M+2.03M
81
Artiva Biotherapeutics
ARTV$25.3M0.1%2.60M+2.60M
82
Quantinuum
QNT$25.0M0.1%306.1K+306.1K
83FRVO$21.9M0.1%750.0K+750.0K
84
Altimmune
ALT$20.4M0.1%6.70M+6.70M
85TOL$18.1M0.1%109.9K+109.9K
86
DPC Holdings
DPC$15.0M0.0%306.1K+306.1K
87
X-Energy
XE$13.1M0.0%714.3K+714.3K
88
Azul
AZUL$12.1M0.0%1.35M+1.35M
89
Rallybio
RLYB$8.4M0.0%524.3K0
90
PepGen
PEPG$6.3M0.0%3.48M0
13F filings arrive up to 45 days after quarter end and cover US-listed long positions only. Positions may have changed since. This is observation data, not a recommendation.

What the latest data says

As of the quarter ended 2026-06-30, Viking Global Investors reported 90 US-listed positions worth $35.08B. The largest is Visa at 6.3% of the reported portfolio, and the top five holdings make up 22% of it, a widely diversified book. New this quarter: Ferrari, MSCI, Union Pacific. Trimmed: Taiwan Semiconductor Manufacturing, Fortive, Charles Schwab.

What this data is

Fund holdings (13F) for Viking Global Investors

Institutional managers with more than $100 million in US equities file a Form 13F within 45 days of each quarter end, listing every long position they held on the last day of the quarter. The site follows a fixed set of 30 managers and turns each filing into a table: the position, its value, its weight in the portfolio and how the share count changed from the previous quarter.

13F data is old by the time it's public, up to 135 days from the trade in the worst case. It won't tell you what a manager did yesterday. It tells you what they own, what they've been building for several quarters, and what they exited.

This page follows Viking Global Investors only. The full list and the cross-market view live on the Fund holdings (13F) hub.

Source and updates

Source
SEC EDGAR Form 13F filings
Credit
SEC.
Updates
Quarterly. Managers file up to 45 days after quarter end, and new filings show here within a week. Latest quarter 2026-06-30.
History
Quarter ended December 2020.
This series
90 positions in the quarter ended 2026-06-30 filing; 35 new, 18 increased, 27 reduced.
Get the data
JSON API and CSV download10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • The change column is the story. A position built over three quarters is conviction; a position that appeared and vanished was a trade.
  • Portfolio weight beats dollar value for comparing managers of different sizes.
  • Treat every 13F number as weeks old and read it for structure, not timing.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Frequently Asked Questions

What does Andreas Halvorsen own?
Viking Global Investors' 13F for the quarter ended 30 June 2026 lists 90 US-listed positions, $35.08B in all. The largest are Visa (6.3%), Taiwan Semiconductor Manufacturing (4.3%), Air Products & Chemicals (4.0%), Sherwin-Williams (3.8%), Fortive (3.5%).
What did Andreas Halvorsen buy last quarter?
New positions in the quarter ended 30 June 2026: Ferrari, MSCI, Union Pacific, DLR, Carnival. Added to: Visa, Air Products & Chemicals, Sherwin-Williams, Meta Platforms, Thermo Fisher Scientific.
What did Andreas Halvorsen sell last quarter?
Reduced in the quarter ended 30 June 2026: Taiwan Semiconductor Manufacturing, Fortive, Charles Schwab, McDonald's, BridgeBio Pharma. Positions sold in full no longer appear in the filing.
How current is Viking Global Investors's portfolio here?
It reflects the latest 13F-HR filing, which managers submit up to 45 days after each quarter ends. Positions may have changed since.
Why do share counts change quarter to quarter?
The QoQ column shows shares bought or sold versus the prior quarter's filing. A position equal to its change is brand new.
Does this show short positions?
No. 13F filings only disclose US-listed long positions. Puts and calls the manager holds are listed on their own lines, valued at the shares they cover; shorts, bonds and non-US holdings are not reported.
What should I read first?
The change column. The largest holding is usually old news; what was added, trimmed or exited this quarter is where the information is.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.